Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Cook

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2000
Cortisol production rates in subjects with suspected Cushing's syndrome: assessment by stable isotope dilution methodology and comparison to other diagnostic methodsM H Samuels, D D Brandon, L M Isabelle, et al.
AAOHN Journal : Official Journal of the American Association of Occupational Health Nurses|April 6, 2011
A family history intervention: enhancing cardiovascular risk assessmentJeanette A McNeill, Jennifer D M Cook, Marveen Mahon, et al.
Journal of Bacteriology|February 29, 2000
TraG from RP4 and TraG and VirD4 from Ti plasmids confer relaxosome specificity to the conjugal transfer system of pTiC58C M Hamilton, H Lee, P L Li, et al.
Annals of Internal Medicine|November 1, 1992
Octreotide treatment of acromegaly. A randomized, multicenter studyS Ezzat, P J Snyder, W F Young, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Hypothalamic pituitary adrenal function in the extremely low birth weight infantC E Hanna, L D Keith, M A Colasurdo, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adultsD M Cook, B M K Biller, M L Vance, et al.
Lancet (London, England)|December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistA J van der Lely, R K Hutson, P J Trainer, et al.
The New England Journal of Medicine|April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2000
Cortisol production rates in subjects with suspected Cushing's syndrome: assessment by stable isotope dilution methodology and comparison to other diagnostic methodsM H Samuels, D D Brandon, L M Isabelle, et al.
AAOHN Journal : Official Journal of the American Association of Occupational Health Nurses|April 6, 2011
A family history intervention: enhancing cardiovascular risk assessmentJeanette A McNeill, Jennifer D M Cook, Marveen Mahon, et al.
Journal of Bacteriology|February 29, 2000
TraG from RP4 and TraG and VirD4 from Ti plasmids confer relaxosome specificity to the conjugal transfer system of pTiC58C M Hamilton, H Lee, P L Li, et al.
Annals of Internal Medicine|November 1, 1992
Octreotide treatment of acromegaly. A randomized, multicenter studyS Ezzat, P J Snyder, W F Young, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Hypothalamic pituitary adrenal function in the extremely low birth weight infantC E Hanna, L D Keith, M A Colasurdo, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adultsD M Cook, B M K Biller, M L Vance, et al.
Lancet (London, England)|December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistA J van der Lely, R K Hutson, P J Trainer, et al.
The New England Journal of Medicine|April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.
Pageof 8